Chemotherapy for advanced CNS ependymoma

Journal of Neuro-Oncology

Volumn 45, Issue 1, 1999, Pages 61-67

  Gornet, M K ^a   Buckner, Jan C ^a   Marks, R S ^a   Scheithauer, B W ^a   Erickson, B J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Advanced; Chemotherapy; CNS; Ependymoma

Indexed keywords

ANTIINFECTIVE AGENT; AZIRIDINYLBENZOQUINONE; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DIANHYDROGALACTITOL; DOXORUBICIN; ETOPOSIDE; LOMUSTINE; NITROSOUREA DERIVATIVE; PLATINUM DERIVATIVE; PROCARBAZINE; SPARFOSIC ACID; TRIAZINATE; VINCRISTINE;

ADOLESCENT; ADULT; ADVANCED CANCER; ALOPECIA; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; DIARRHEA; DOSE TIME EFFECT RELATION; EPENDYMOMA; FATIGUE; FEMALE; HEARING LOSS; HEPATITIS; HUMAN; MALE; NAUSEA; RETROSPECTIVE STUDY; TINNITUS; VOMITING;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; EPENDYMOMA; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NITROSOUREA COMPOUNDS; PLATINUM; RETROSPECTIVE STUDIES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0033493761     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006394407245     Document Type: Article

References (14)

1. Mork SJ, Loken AC: Ependymoma: a follow-up or 101 cases. Cancer 40: 907-915, 1997
2. Russell DJ, Rubinstein LJ: Pathology of Tumors of the Nervous System. 5th edn, Williams & Wilkins, Baltimore, 1989
3. Leibel SA, Sheline GE: Radiation therapy for neoplasms of the brain. J Neurosurg 66: 1, 1987
4. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System. 2nd edn, Springer-Verlag, Berlin, 1993, pp 17-18
5. Geyer JR, Zelter PM, Boyett JM, Rorke LB, Stanley P, Albright AL, et al.: Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Children's Cancer Group. J Clin Oncol 12: 1607-1615, 1994
6. Bertolone JS, Baum ES, Krivit W, Hammond GD: A phase II study of cisplatin therapy in recurrent childhood brain tumors: a report from the Children's Cancer Study Group. J Neuro-Oncol 7: 5-11, 1989
7. Goldwein JW, Glauser TA, Packer RJ, Finlay JL, Sutton LN, Curran WJ et al.: Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors. Cancer 66: 557-563, 1990
8. Sexauer CL, Khan A, Burger PC, Krischer JP, van Eys J, Vats T et al.: Cisplatin in recurrent pediatric brain tumors: a POG phase II study. Cancer 56: 1497-1501, 1985
9. MacDonald DR, Cascino TL, Schold SC Jr, Cairncross JG: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8(7): 1277-1280, 1990
10. Ettinger LJ, Ru N, Krailo M, Ruccione KS, Krivit W, Hammond GD: A phase II study of diaziquone in children with recurrent or progressive primary brain tumors: a report from the Children's Cancer Study Group. J Neuro-Oncol 9: 69-76, 1990
11. Gaynon PS, Ettinger LJ, Baum ES, Siegel SE, Krailo MD, Hammond GD: Carboplatin in childhood brain tumors: a Children's Cancer Study Group phase II trial. Cancer 66: 2465-2469, 1990
12. Levin VA, Edwards MS, Gutin PH, Vestnys P, Fulton D, Seager M et al.: Phase II evaluation of dibromodulcitol in the treatment of recurrent medulloblastoma, ependymoma, and malignant astrocytoma. J Neurosurg 61: 1063-1068, 1984
13. Levin VA. Chemotherapy of primary brain tumors. Neurologic Clinics 3: 855-865, 1985
14. De Vita VT, Stellman S, Rosenberg SA: Cancer: Principles and Practice of Oncology. 5th edn, Lippincott-Raven, Philadelphia, 1997